These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 19523823)
1. Effect of varying chain length between P(1) and P(1') position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors. Chaudhary S; Vats ID; Chopra M; Biswas P; Pasha S Bioorg Med Chem Lett; 2009 Aug; 19(15):4364-6. PubMed ID: 19523823 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study between Ornithyl-Proline and Lysyl-Proline based tripeptidomimics as angiotensin-converting enzyme inhibitors. Pavar MC; Hanif K; Azam A; Lata S; Qadar Pasha MA; Pasha S Bioorg Med Chem Lett; 2006 Apr; 16(8):2117-21. PubMed ID: 16464585 [TBL] [Abstract][Full Text] [Related]
3. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors. Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427 [TBL] [Abstract][Full Text] [Related]
4. Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors. Tzakos AG; Gerothanassis IP Chembiochem; 2005 Jun; 6(6):1089-103. PubMed ID: 15883972 [TBL] [Abstract][Full Text] [Related]
5. Novel peptidomimics as angiotensin-converting enzyme inhibitors: a combinatorial approach. Bala M; Qadar Pasha MA; Bhardwaj DK; Pasha S Bioorg Med Chem; 2002 Nov; 10(11):3685-91. PubMed ID: 12213484 [TBL] [Abstract][Full Text] [Related]
6. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates. Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828 [TBL] [Abstract][Full Text] [Related]
7. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain. Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500 [TBL] [Abstract][Full Text] [Related]
8. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme. Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors. Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442 [TBL] [Abstract][Full Text] [Related]
16. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition. Ottaviani JI; Actis-Goretta L; Villordo JJ; Fraga CG Biochimie; 2006; 88(3-4):359-65. PubMed ID: 16330143 [TBL] [Abstract][Full Text] [Related]
17. Development of domain-selective angiotensin I-converting enzyme inhibitors. Redelinghuys P; Nchinda AT; Sturrock ED Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme. Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action. Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251 [TBL] [Abstract][Full Text] [Related]
20. The molecular mechanisms of interactions between bioactive peptides and angiotensin-converting enzyme. Pan D; Guo H; Zhao B; Cao J Bioorg Med Chem Lett; 2011 Jul; 21(13):3898-904. PubMed ID: 21640589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]